Subscribe To
Following disappointing earnings, expect paypal stock to fall further
The worst isn't over for PayPal as the economic conditions look unfavourable. PYPL stock might continue...
May 6, 2022, 11:32 am
Stellantis says q1 sales rose 12% on strong pricing and vehicle mix
Carmaker Stellantis said on Thursday its sales rose 12% in the first quarter of this year supported by strong pricing and vehicle mix, but also by
May 5, 2022, 2:13 am
Novartis earnings edge higher on cosentyx, entresto
Core operating income at Novartis edged 3% higher in the first quarter as sales growth from new drugs was partly offset by un...
April 26, 2022, 1:29 am
Hyundai motor q1 profit surges on favourable currency rate
Hyundai Motor Co on Monday posted a 19% rise in first-quarter profit as favourable exchange rates offse...
April 25, 2022, 1:09 am
Anglo pacific hails favourable legal ruling in four mile royalty dispute
Anglo Pacific Group PLC (LSE:APF, TSX:APY, OTC:AGPIF) announced a favourable ruling in its legal disput...
April 19, 2022, 3:39 am
Gold futures mark highest settlement in nearly a week
Gold futures rallied on Wednesday to settle at their highest in almost a week. The U.S. Federal Reserve has "marked out a series of planned interest r...
March 23, 2022, 1:33 pm
Advance auto parts: strong difm presence, margin expansion potential and favourable macros
Advance Auto Parts will benefit from a recovery in miles driven and ageing vehicles....
February 23, 2022, 3:21 pm
Advance auto parts: strong difm presence, margin expansion potential and favourable macros
Advance Auto Parts will benefit from a recovery in miles driven and ageing vehicles....
February 23, 2022, 3:21 pm
Advance auto parts: strong difm presence, margin expansion potential and favourable macros
Advance Auto Parts will benefit from a recovery in miles driven and ageing vehicles....
February 23, 2022, 3:21 pm
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am